Literature DB >> 3021814

Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.

K Midthun, Y Hoshino, A Z Kapikian, R M Chanock.   

Abstract

A series of reassortants was isolated from coinfection of cell cultures with wild-type bovine rotavirus (UK strain [serotype 6]) or rhesus rotavirus (strain MMU18006 [serotype 3]) and a tissue culture-adapted human rotavirus strain, ST3 (serotype 4). Monospecific antiserum or a set of monoclonal antibodies to the major outer capsid neutralization glycoprotein, VP7, of the animal rotavirus parent was used to select for reassortants with human rotavirus serotype 4 neutralization specificity. The majority of reassortants contained only gene 9 of the human rotavirus parent, ST3, whereas the remaining genes were derived from the animal rotavirus parent. These single human rotavirus gene substitution reassortants were neutralized to high titer by hyperimmune serum directed at ST3, thus demonstrating that gene 9 of ST3 codes for the major neutralization protein of this strain. Moreover, these single gene substitution, reassortants were also neutralized to low titer by antiserum directed at their animal rotavirus parent, probably because they derived gene 4, which codes for another outer capsid protein, VP3, from their animal rotavirus parent. None of the reassortants derived gene 4, which had previously been shown to be responsible for host range restriction of human rotaviruses in tissue culture, from ST3, despite the fact that the ST3 strain used for gene reassortment had been tissue culture adapted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021814      PMCID: PMC269035          DOI: 10.1128/jcm.24.5.822-826.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Reassortant rotaviruses as potential live rotavirus vaccine candidates.

Authors:  K Midthun; H B Greenberg; Y Hoshino; A Z Kapikian; R G Wyatt; R M Chanock
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Nucleotide sequence of the gene encoding the serotype-specific antigen of human (Wa) rotavirus: comparison with the homologous genes from simian SA11 and UK bovine rotaviruses.

Authors:  M A Richardson; A Iwamoto; N Ikegami; A Nomoto; Y Furuichi
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  Sequence homology between human and animal rotavirus serotype-specific glycoproteins.

Authors:  M L Dyall-Smith; I H Holmes
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

5.  Subhuman primate diploid cells: possible substrates for production of virus vaccines.

Authors:  J C Petricciani; H E Hopps; D E Lorenz
Journal:  Science       Date:  1971-12-03       Impact factor: 47.728

6.  Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

Authors:  Y Hoshino; M M Sereno; K Midthun; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Primary structure of the neutralization antigen of simian rotavirus SA11 as deduced from cDNA sequence.

Authors:  C F Arias; S López; J R Bell; J H Strauss
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses.

Authors:  R I Glass; J Keith; O Nakagomi; T Nakagomi; J Askaa; A Z Kapikian; R M Chanock; J Flores
Journal:  Virology       Date:  1985-03       Impact factor: 3.616

10.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; J Flores; A Z Kapikian
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

View more
  35 in total

1.  Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.

Authors:  Max Ciarlet; Juan E Ludert; Miren Iturriza-Gómara; Ferdinando Liprandi; James J Gray; Ulrich Desselberger; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses.

Authors:  D A Kool; S M Matsui; H B Greenberg; I H Holmes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assays.

Authors:  R L Ward; A Z Kapikian; K M Goldberg; D R Knowlton; M W Watson; R Rappaport
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.

Authors:  R L Ward; D R Knowlton; H B Greenberg; G M Schiff; D I Bernstein
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.

Authors:  K Midthun; L Z Pang; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Acrylamide concentration affects the relative position of VP7 gene of serotype G2 strains as determined by polyacrylamide gel electrophoresis.

Authors:  Jerri Ross; Eileen N Ostlund; Dianjun Cao; Masatoshi Tatsumi; Yasutaka Hoshino
Journal:  J Clin Virol       Date:  2008-05-23       Impact factor: 3.168

9.  Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.

Authors:  J Flores; I Perez-Schael; M Blanco; A M Rojas; E Alfonzo; I Crespo; W Cunto; A L Pittman; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Molecular analysis of the VP7, VP4, VP6, NSP4, and NSP5/6 genes of a buffalo rotavirus strain: identification of the rare P[3] rhesus rotavirus-like VP4 gene allele.

Authors:  V Martella; M Ciarlet; A Pratelli; S Arista; V Terio; G Elia; A Cavalli; M Gentile; N Decaro; G Greco; M A Cafiero; M Tempesta; C Buonavoglia
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.